Nabi Biopharmaceuticals (NABI) Reports Q4 Loss of $0.05
Tweet
Share
E-mailGet Alerts NABI Hot Sheet
Price: $1.80 --0%
Financial Fact:
Basic income (loss) per share: -0.26
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Basic income (loss) per share: -0.26
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Nabi Biopharmaceuticals (NASDAQ: NABI) reported Q4 EPS of ($0.05), versus ($0.08) reported last year.
For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.
For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- CoStar Group acquires Zonda for $800M, adding new home data
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
